Redmile Group, LLC Horizon Therapeutics Public LTD CO Transaction History

Redmile Group, LLC

  • $1.53 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$79.4 - $116.36 $72.5 Million - $106 Million
913,319 New
913,319 $72.8 Million
Q4 2019

Feb 14, 2020
SELL
$25.43 - $36.67 $373,821 - $539,049
-14,700 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$23.0 - $27.97 $75,900 - $92,301
3,300 Added 28.95%
14,700 $400,000
Q2 2019

Aug 14, 2019
BUY
$22.81 - $28.48 $260,033 - $324,672
11,400 New
11,400 $274,000

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email